Atea Pharmaceuticals, Inc. (AVIR)
4.115
-0.20
(-4.52%)
USD |
NASDAQ |
Oct 30, 16:00
4.115
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Price : 4.115 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | 4.30 | 4.50 | 4.26 | 4.31 | 280875.0 |
| Oct 28, 2026 | 4.15 | 4.27 | 4.14 | 4.27 | 328415.0 |
| Oct 27, 2026 | 4.14 | 4.290 | 4.05 | 4.17 | 245240.0 |
| Oct 26, 2026 | 4.04 | 4.24 | 3.94 | 4.16 | 251086.0 |
| Oct 23, 2026 | 4.03 | 4.11 | 3.93 | 4.04 | 245442.0 |
| Oct 22, 2026 | 4.08 | 4.17 | 4.02 | 4.05 | 318759.0 |
| Oct 21, 2026 | 4.47 | 4.47 | 4.05 | 4.08 | 465228.0 |
| Oct 20, 2026 | 4.34 | 4.58 | 4.315 | 4.465 | 288829.0 |
| Oct 19, 2026 | 4.34 | 4.42 | 4.17 | 4.39 | 390039.0 |
| Oct 16, 2026 | 4.54 | 4.55 | 4.30 | 4.32 | 345876.0 |
| Oct 15, 2026 | 4.64 | 4.805 | 4.48 | 4.53 | 319365.0 |
| Oct 14, 2026 | 4.92 | 4.92 | 4.60 | 4.63 | 414460.0 |
| Oct 13, 2026 | 5.03 | 5.04 | 4.87 | 4.98 | 303227.0 |
| Oct 12, 2026 | 5.13 | 5.20 | 5.03 | 5.03 | 190705.0 |
| Oct 09, 2026 | 5.15 | 5.23 | 5.09 | 5.15 | 157968.0 |
| Oct 08, 2026 | 4.98 | 5.23 | 4.91 | 5.155 | 350918.0 |
| Oct 07, 2026 | 5.02 | 5.23 | 4.99 | 5.01 | 264766.0 |
| Oct 06, 2026 | 5.16 | 5.19 | 4.98 | 5.07 | 229368.0 |
| Oct 05, 2026 | 5.12 | 5.18 | 4.945 | 5.13 | 293607.0 |
| Oct 02, 2026 | 5.16 | 5.215 | 5.05 | 5.13 | 253264.0 |
| Oct 01, 2026 | 5.16 | 5.20 | 4.93 | 5.10 | 408661.0 |
| Sep 30, 2026 | 5.20 | 5.29 | 5.14 | 5.21 | 296282.0 |
| Sep 29, 2026 | 5.20 | 5.23 | 5.08 | 5.18 | 298348.0 |
| Sep 28, 2026 | 5.15 | 5.30 | 5.10 | 5.20 | 238374.0 |
| Sep 25, 2026 | 5.16 | 5.21 | 5.04 | 5.17 | 280667.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Filana Therapeutics, Inc. | 0.623 |
| CorMedix, Inc. | 5.695 |
| Eloxx Pharmaceuticals, Inc. | 13.28 |
| Breakthrough Chemistry, Inc. | 0.088 |
| BioStem Technologies, Inc. | 1.12 |
Price Related Metrics
| PEG Ratio | -0.0662 |
| Price to Book Value | 1.617 |
| Earnings Yield | -50.82% |
| Market Cap | 330.04M |
| PEGY Ratio | -0.0662 |